• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

301
74
50
50
35

COUNTRY

34
12
12
11
11

PRICE

782
930
1,346
1,706

PUBLISHED

23
46
312
1,706

PRODUCT TYPE

1,104
499
85
16
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Pulmonary Tuberculosis - Pipeline Review, H2 2013

Pulmonary Tuberculosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM

Meningococcal Meningitis - Pipeline Review, H2 2013

Meningococcal Meningitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Meningococcal Meningitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

October 2013
FROM
2014 Analysis of the French Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies 2014 Analysis of the French Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies - Product Thumbnail Image

2014 Analysis of the French Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies

2014 Opportunities in the French Infectious Disease Testing Market is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five...

October 2013
FROM

Infection Control for Advanced Practice Professionals

This professional reference combines research on the best practices for infection control in clinical settings with essential information for advanced practice nurses and physician assistants The book...

October 2013

PharmaPoint: Meningococcal Vaccines - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Spain Drug Forecast...

September 2013
FROM

MnB rLP2086 (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

MnB rLP2086 (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - US Drug Forecast and...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Germany Drug...

September 2013
FROM

Typhoid Fever Global Clinical Trials Review, H2, 2013

Typhoid Fever Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Typhoid Fever Global Clinical Trials Review, H2, 2013" provides data on the Typhoid Fever clinical trial scenario....

September 2013
FROM

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - Italy Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Italy Drug Forecast...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and...

September 2013
FROM

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

Menomune (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menomune (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

Warts Global Clinical Trials Review, H2, 2013

Warts Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Warts Global Clinical Trials Review, H2, 2013" provides data on the Warts clinical trial scenario. This report provides...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast...

September 2013
FROM

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

Menactra (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menactra (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM

PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Australia Drug...

September 2013
FROM

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid...

September 2013
FROM
Loading Indicator

Our Clients

Our clients' logos